본문바로가기
About Us
SK bioscience
Company Overview
History
Vision
Contact Us
Leadership
Message from the CEO
Headquarters & Facilities
SK bioscience Headquarters
R&D Center
L HOUSE
Subsidiary
SK bioscience USA
IDT Biologika
Science & Technology
Pipeline
R&D
Production
Business
Business Overview
Domestic
Overseas Business
Vaccine Co-Development
and Technology Transfer
CDMO/CMO
Products
In-house Products
Outsourced Products
Global Partnerships
ESG
새창열기 아이콘
IR
Corporate Governance
Company Information
Financial Information
Financial Statements
Financial Credit
Audit Reports
Investment Information
Stock Prices
Shareholder Status
IR Documents
Disclosure
PR
Press Releases
Media Zoom
Brochure
CI Guideline
sitemap
About Us
SK bioscience
Company Overview
History
Vision
Contact Us
Leadership
Message from the CEO
Headquarters & Facilities
SK bioscience Headquarters
R&D Center
L HOUSE
Subsidiary
SK bioscience USA
IDT Biologika
Science & Technology
Pipeline
R&D
Production
Business
Business Overview
Domestic
Overseas Business
Vaccine Co-Development
and Technology Transfer
CDMO/CMO
Products
In-house Products
Outsourced Products
Global Partnerships
ESG
IR
Corporate Governance
Company Information
Financial Information
Financial Statements
Financial Credit
Audit Reports
Investment Information
Stock Prices
Shareholder Status
IR Documents
Disclosure
PR
Press Releases
Media Zoom
Brochure
CI Guideline
사이트맵 닫기
Language
KOR
ENG
LinkedIn
YouTube
ESG
SK careers
C/S
SK ethics
Q
U
I
C
K
PR
SK bioscience company news updates
PR
About Us
Science & Technology
Business
ESG
IR
PR
Media Zoom
Press Releases
Media Zoom
Brochure
CI Guideline
Media Zoom
2022 IVI-SK bioscience Park MahnHoon Award Ceremony honors Dr. Tore Godal, Profs. Drew Weissman & Katalin Kariko
2022.04.25
SK advances Gates-backed COVID-19 antiviral spray toward clinic
2022.04.19
Next Big Step: SK Bioscience Gears Up For Endemic COVID, Next Pandemic
2022.04.04
Antibodies in children last at least 6 months after COVID; SK Bioscience vaccine shows promise vs Omicron
2022.03.23
South Korea to buy 10 million doses of SK Bioscience´s COVID vaccine
2022.03.21
SK Bioscience developing combo flu and COVID-19 vaccine, a first of its kind in South Korea
2022.02.25
SK Bioscience rolls out 1st batch of Novavax vaccine
2022.02.09
Variant-proofing vaccines: Novel candidates seek to offer broad protection
2022.01.11
Korea set to approve Novavax COVID-19 vaccine by this month
2022.01.08
처음
이전
1
2
3
4
다음
끝